Skip to content
Review Open access

Metabolomics in the Diagnosis, Prognosis, and Subphenotyping of Sepsis

2026 · American Journal of Student Research · 0 citations

Abstract

Sepsis is a severe response to infection that can lead to dysfunction of multiple organs. Sepsis can lead to acute respiratory distress syndrome (ARDS), the form of acute lung injury that can occur following pulmonary or extrapulmonary sepsis. Sepsis and ARDS carry high mortality rates, and treatments are limited due to delayed diagnosis, poor prognostic prediction, unexplained heterogeneity between patients, and incomplete understanding of the underlying disease mechanisms. This review examines how metabolomics — the measurement of small-molecule metabolites in the body — has been used to address each of these four gaps. Diagnosis studies compare metabolite levels between patients with and without sepsis to identify patterns enabling rapid detection. Prognosis studies use metabolite patterns to predict patient outcomes. Subphenotyping and precision medicine studies address sepsis’s heterogeneity to allow treatments to be better matched to the individual. Studies aimed at mechanism examine whether specific metabolites actually cause sepsis, pointing toward potential new drug targets.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.